Risk Factors and Outcomes of Infections Caused by Extremely Drug-Resistant Gram-Negative Bacilli in ICU Patients

Extremely drug-resistant gram-negative bacilli (XDR-GNB) are increasingly responsible for healthcare-associated infections (HAIs) in intensive care units (ICUs), posing significant challenges to patient management and outcomes. This study investigated the risk factors and mortality outcomes associated with XDR-GNB HAIs among critically ill patients. A matched case-control study was conducted from February 2007 to January 2010 across 16 ICUs affiliated with NewYork-Presbyterian Hospital. Case subjects had HAIs caused by GNB resistant to all but one antibiotic, while control subjects had infections due to non-XDR GNB, susceptible to at least two antibiotics. Logistic regression identified independent risk factors for XDR-GNB HAIs: immunocompromised state (OR=1.3-Penten-2-one Cancer 55, p=0.047), exposure to amikacin (OR=13.81, p<0.001), levofloxacin (OR=2.05, p=0.005), and trimethoprim-sulfamethoxazole (OR=3.42, p=0.009). These findings suggest that prior antimicrobial exposure and host immune status significantly contribute to the development of XDR-GNB infections. Survival analysis revealed that mortality predictors varied over time after HAI diagnosis.6-Phenylpyridine-2-carboxylic acid custom synthesis At 7 days post-diagnosis, liver disease (HR=5.PMID:34116571 52), immunocompromised state (HR=3.41), and bloodstream infection (HR=2.55) were independently associated with increased risk of death. By day 15, age (HR=1.02 per year increase), liver disease (HR=3.34), and immunocompromised state (HR=2.03) remained significant predictors. At 30 days, age (HR=1.02), liver disease (HR=3.34), immunocompromised state (HR=2.03), and hospitalization in a medical ICU (HR=1.85) predicted mortality. Notably, XDR-GNB infection itself was not an independent predictor of mortality at any time point. Instead, underlying comorbidities—particularly liver disease and immunosuppression—were consistently linked to higher mortality rates.

Treatment patterns also differed between groups. Case subjects received more antibiotics on average (mean 3.8 vs. 3.1), had longer time to effective therapy (3.0 vs. 1.3 days), and were less likely to receive effective treatment within 7 days (83% vs. 96%). However, duration of therapy and persistence of positive blood cultures did not differ significantly. Despite higher overall mortality in the XDR-GNB group (59% vs. 31%), the attributable effect of the pathogen on death was not confirmed in multivariable models. The results underscore the importance of managing comorbid conditions and optimizing antibiotic stewardship to prevent the emergence and spread of XDR-GNB in ICUs.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com